Based on the Gene Expression Omnibus (GEO) database, GZMA, PRC1 and TTK were enriched in the innate immune cell-mediated immune response and immune-related biological processes, validating them as potential targets for rheumatoid arthritis (RA) therapy (Cheng et al., 2021). This evidence concerns the gene PRC1 and rheumatoid arthritis.